Skip to content
Wenlo
Sign in
← Markets

ResMed Inc.

Justin Leong (Chief Product Officer) reports RMD insider transactions

4RMDFiled Nov 20, 2026, 4:58 PM ET· Period Nov 19, 2026

AI-generated summary

Justin Leong, Chief Product Officer of ResMed Inc., received 10,314 shares as a grant on November 19, 2026. After this transaction, the insider directly held 10,314 shares. The grant represents performance-based restricted stock units earned after meeting performance metrics.

Key facts

Insider
Justin Leong · Chief Product Officer
DateTransactionSharesPriceValueHeld afterOwnership
Nov 19, 2026A · grantFootnotes F1+10,314$0.00$0.0010,314Direct
Footnotes
  1. F1 Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on November 19, 2026, when the compensation and leadership development committee certified that the performance metrics were met for this portion of the grant.

More RMD filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.